|
TEL: +32 16 58 90 45
Fax :+ 32 16 50 90 45
GENTAUR Europe
tel+32 2 732 5688
fax+32 2 732 4414
Av.
de l' Armιe 68
B-1040 BRUSSELS
BELGIUM
GENTAUR France
tel 01 43 25
01 50
fax01 43 25
01 60
9, rue
Lagrange
75005 PARIS
FRANCE
GENTAUR Italy
tel 02 36 00
65 93
fax 02 36 00
65 94
20135 MILANO
ITALY
GENTAUR Germany
tel +49 241
6085 13140
fax +49 241
6085 33033
Forckenbeckstraίe 6,
D-52074
Aachen
GERMANY
| |
| ATGen products
listed by category: |
 |
| Apoptosis, tumour
suppressor and tumour marker [4] |
|
| Cell cycle
proteins [6] |
|
| Growth Factors; Growth Factor Receptors and Hormones [14] |
|
|
Kinases & Phosphatases [6] |
|
|
Lymphocyte Signalling [14] |
|
|
Neurobiology [26] |
|
|
Obesity [2] |
|
|
Receptors and transporters [2] |
|
|
Signalling Intermediates [22] |
|
|
Support Products and Kits [1] |
|
|
Synthesis and Degradation [4] |
|
|
Transcription Factors; DNA Damage and Repair [4] |
|
Apoptosis, tumour suppressor and tumour marker |
 |
|
|
 |
|
|
UBC3002 |
|
Ubiquitin, human recombinant |
465 |
|
|
|
|
|
|
|
|
|
UBC3052 |
|
Ubiquitin, human recombinant |
132,20 |
|
|
|
|
|
|
|
|
|
VHL3001 |
|
VHL
protein, human recombinant |
465 |
|
|
|
|
|
|
|
|
|
VHL3051 |
|
VHL
protein, human recombinant |
199,40 |
|
|
|
|
|
|
|
|
|
|
Cell cycle proteins |
|
|
|
|
|
|
|
|
CBP3001 |
|
CEBP-alpha, human recombinant |
465 |
|
|
|
|
|
|
|
|
|
CBP3003 |
|
CEBP-gamma, human recombinant |
465 |
|
|
|
|
|
|
|
|
|
CBP3051 |
|
CEBP-alpha, human recombinant |
199,40 |
|
|
|
|
|
|
|
|
|
CBP3053 |
|
CEBP-gamma, human recombinant |
199,40 |
|
|
|
|
|
|
|
|
|
POZ3001 |
|
GAGA-POZ domain (1-130aa), recombinant |
465 |
|
|
|
|
|
|
|
|
|
POZ3051 |
|
GAGA-POZ domain (1-130aa), recombinant |
199,40 |
|
|
|
|
|
|
|
|
|
|
Growth Factors; Growth Factor Receptors and Hormones |
|
|
|
|
|
|
|
|
ADI3001 |
|
Adiponectin, mouse recombinant |
465 |
|
|
|
|
|
|
|
|
|
ADI3051 |
|
Adiponectin, mouse recombinant |
132,20 |
|
|
|
|
|
|
|
|
|
AGH0401 |
|
Growth
Hormone, monoclonal |
279,40 |
|
|
|
|
|
|
|
|
|
AGH0451 |
|
Growth
Hormone, monoclonal |
193 |
|
|
|
|
|
|
|
|
|
CSF4001 |
|
G-CSF,
human recombinant |
465 |
|
|
|
|
|
|
|
|
|
CSF4051 |
|
G-CSF,
human recombinant |
132,20 |
|
|
|
|
|
|
|
|
|
GRH3001 |
|
Growth
Hormone, human recombinant |
465 |
|
|
|
|
|
|
|
|
|
GRH3002 |
|
Growth
Hormone, 20kDa, human recombinant |
465 |
|
|
|
|
|
|
|
|
|
GRH3051 |
|
Growth
Hormone, human recombinant |
737 |
|
|
|
|
|
|
|
|
|
GRH3052 |
|
Growth
Hormone, 20kDa, human recombinant |
132,20 |
|
|
|
|
|
|
|
|
|
IFG4001 |
|
Interferon-gamma, human recombinant |
465 |
|
|
|
|
|
|
|
|
|
IFG4051 |
|
Interferon-gamma, human recombinant |
132,20 |
|
|
|
|
|
|
|
|
|
PTH3001 |
|
Parathyroid Hormone, human recombinant |
465 |
|
|
|
|
|
|
|
|
|
PTH3051 |
|
Parathyroid Hormone, human recombinant |
132,20 |
|
|
|
|
|
|
|
|
|
|
Lymphocyte Signalling |
|
|
|
|
|
|
|
|
AKR0408 |
|
NKp46,
monoclonal |
279,40 |
|
|
|
|
|
|
|
|
|
AKR0458 |
|
NKp46,
monoclonal |
193 |
|
|
|
|
|
|
|
|
|
AKR3006 |
|
KIR2DL3, monoclonal |
279,40 |
|
|
|
|
|
|
|
|
|
AKR3007 |
|
LAIR-1,
monoclonal |
279,40 |
|
|
|
|
|
|
|
|
|
AKR3056 |
|
KIR2DL3, monoclonal |
193 |
|
|
|
|
|
|
|
|
|
AKR3057 |
|
LAIR-1,
monoclonal |
193 |
|
|
|
|
|
|
|
|
|
KIR3001 |
|
KIR2DL1(p58 KIR, CD138), human recombinant |
705 |
|
|
|
|
|
|
|
|
KIR3002 |
|
KIR2DL3
(p58 KIR, CD138), human recombinant |
705 |
|
|
|
|
|
|
|
|
KIR3003 |
|
KIR2DS4
(p50 KIR, CD158), human recombinant |
705 |
|
|
|
|
|
|
KIR3004 |
|
KIR3DL1, human recombinant |
705 |
|
|
|
|
|
|
|
|
KIR3051 |
|
KIR2DL1(p58 KIR, CD138), human recombinant |
279,40 |
|
|
|
|
|
|
|
|
KIR3052 |
|
KIR2DL3
(p58 KIR, CD138), human recombinant |
279,40 |
|
|
|
|
|
|
|
|
KIR3053 |
|
KIR2DS4
(p50 KIR, CD158), human recombinant |
279,40 |
|
|
|
|
|
|
|
|
KIR3054 |
|
KIR3DL1, human recombinant |
279,40 |
|
|
|
|
|
|
|
|
|
Neurobiology |
|
|
|
|
|
|
|
|
SNA2001 |
|
alpha-Synuclein, human recombinant |
119,40 |
|
|
|
|
|
|
|
|
SNA2002 |
|
alpha-Synuclein A53T, human recombinant |
185 |
|
|
|
|
|
|
|
|
SNA2003 |
|
alpha-Synuclein A30P, human recombinant |
119,40 |
|
|
|
|
|
|
|
|
SNA2004 |
|
alpha-Synuclein A30P/A53T, recombinant |
385 |
|
|
|
|
|
|
|
|
SNA2005 |
|
alpha-Synuclein 112 (NACP112), human recombinant |
385 |
|
|
|
|
|
|
|
|
SNA2006 |
|
alpha-Synuclein 61-140, human recombinant |
119,40 |
|
|
|
|
|
|
|
|
SNA2007 |
|
alpha-Synuclein 96-140, human recombinant |
119,40 |
|
|
|
|
|
|
|
|
SNA2008 |
|
alpha-Synuclein Delta-NAC, human recombinant |
385 |
|
|
|
|
|
|
|
|
SNA2051 |
|
alpha-Synuclein, human recombinant |
385 |
|
|
|
|
|
|
|
|
SNA2052 |
|
alpha-Synuclein A53T, human recombinant |
119,40 |
|
|
|
|
|
|
|
|
SNA2053 |
|
alpha-Synuclein A30P, human recombinant |
119,40 |
|
|
|
|
|
|
|
|
SNA2054 |
|
alpha-Synuclein A30P/A53T, recombinant |
385 |
|
|
|
|
|
|
|
|
SNA2055 |
|
alpha-Synuclein 112 (NACP112), human recombinant |
385 |
|
|
|
|
|
|
|
|
SNA2056 |
|
alpha-Synuclein 61-140, human recombinant |
385 |
|
|
|
|
|
|
|
|
SNA2057 |
|
alpha-Synuclein 96-140, human recombinant |
385 |
|
SNA2058 |
|
alpha-Synuclein Delta-NAC, human recombinant |
385 |
|
|
|
|
|
|
|
|
SNA3009 |
|
alpha-Synuclein 1-60, human recombinant |
385 |
|
|
|
|
|
|
|
|
SNA3059 |
|
alpha-Synuclein 1-60, human recombinant |
385 |
|
|
|
|
|
|
|
|
SNA4001 |
|
alpha-Synuclein E46K, human recombinant |
385 |
|
|
|
|
|
|
|
|
SNA4002 |
|
alpha-Synuclein 1-95, human recombinant |
119,40 |
|
|
|
|
|
|
|
|
SNA4051 |
|
alpha-Synuclein E46K, human recombinant |
119,40 |
|
|
|
|
|
|
|
|
SNA4052 |
|
alpha-Synuclein 1-95, human recombinant |
119,40 |
|
|
|
|
|
|
|
|
SNG2001 |
|
gamma-Synuclein (BCSG1), human recombinant |
119,40 |
|
|
|
|
|
|
|
|
SNG2001 |
|
gamma-Synuclein, human recombinant |
119,40 |
|
|
|
|
|
|
|
|
SNG2051 |
|
gamma-Synuclein (BCSG1), human recombinant |
119,40 |
|
|
|
|
|
|
|
|
SNG2051 |
|
gamma-Synuclein, human recombinant |
119,40 |
|
|
|
|
|
|
|
